<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog


Recent Posts

2 min read

What's on the Horizon? Q221 Spine Market Recap

By Julianne Burns on 10/8/21 9:50 AM

The US Spine market appears to be continuing on a skyward trajectory...but what’s really on the horizon for Spine?

With Q221 year-over-year growth up almost 46%, the US Spine market appears to be continuing on a skyward trajectory. However, as compared to Q219, Q221 saw growth of only +1.3%, reflecting ongoing COVID challenges. What’s really on the horizon for Spine? While the first half of 2021 has certainly looked much brighter than 2020, one big question remains: how big of an impact will the Delta variant surge have on the back half of the year?

Among the many topics covered in detail in our comprehensive Q221 Spine Market Recap* are:

Continue Reading
2 min read

Looking Up: Q121 Spine Market Recap

By Julianne Burns on 6/18/21 9:30 AM

As the impact of COVID continues to decrease, things are looking up for the Spine market. 

Q121 heralded what we all hope is the rebound from the COVID-related downturn, driven by healthcare resource prioritization and the postponement of non-emergent surgeries. The WW Spine Hardware achieved robust growth, according to SmartTRAK Financial Dashboard. Although January and February were again impacted by COVID, procedure volumes improved throughout the quarter, with Alphatec* (ATEC), NuVasive* (NUVA) and SeaSpine* (SPNE) all specifically calling out an uptick around the March timeframe.

Topics: Spine
Continue Reading
2 min read

Faltering Under the Weight: Q420/FY20 Spine Market Recap

By Julianne Burns on 4/9/21 7:30 AM

An initially promising Q4 faltered under the weight of the COVID-19 resurgence, leading to a Q420 WW Spine Hardware Market decline of -1.0%. 

The continued rebound that everyone had been hoping for was dampened by the COVID-19 resurgence in Q420. While the quarter got off to a promising start, COVID headwinds picked up negatively impacting Spine procedure volumes due to challenges with hospital resource utilization and renewed restrictions around elective procedures. For example, NuVasive* management noted that the Company entered Q4 with relatively stable case volumes but experienced market disruption from the resurgence of COVID-19 at the exit of the quarter, most notably in parts of the US and Europe.

Among the many topics covered in the comprehensive Q420/FY20 Spine Market Recap * are:

Topics: Spine
Continue Reading
2 min read

Spine's Next Big Biomaterial: DiFusion Technologies’ ZFUZE

By Julianne Burns on 4/6/21 7:45 AM

Derrick Johns, President and CEO of DiFusion Technologies, discusses the challenges and opportunities associated with developing and commercializing a new biomaterial in an interview with SmartTRAK. 

Nearly every company in Spine (and dare we say all of Orthopedics) is working to find the holy grail of biomaterials for interbody implants and more. DiFusion Technologies’ President and CEO Derrick Johns discusses the challenges and opportunities associated with bringing a novel material to market in an interview with SmartTRAK.

To listen to the interview, recorded live via Zoom, click on the following video. A link to download a complete transcript of the interview is also provided below.

Topics: Spine
Continue Reading
2 min read

Top Trends in Spine in 2021: A Market in Motion

By Julianne Burns on 2/22/21 11:14 AM

Tracking which procedures will drive growth within the Spine hardware market as we ride the ups and downs of COVID-19.

Following a Q320 rebound in elective procedures sparking a return to growth for the COVID-ravaged Spine market, the recent COVID resurgence has once again dragged US Spine growth rates down. While many companies have yet to report Q420 earnings, early signs point to a downturn, with procedure volumes impacted by hospital resource utilization and renewed restrictions around elective procedures.

In this article, Julianne Burns, SmartTRAK's GM, Spine, looks at the following topics:

  • The COVID Impact Update
  • Shifts in Cervical Total Disc Replacement (cTDR)
  • Growth in Prone Lateral Procedures
  • Expansion in SI Joint Fusion
  • Innovation in Interbody Materials
Continue Reading
2 min read

Robotic Installations Shatter Expectations: Q320 CAS Ortho Market Recap

By Julianne Burns on 12/28/20 11:50 AM

Orthopedic Robotic Installations Continued to Shatter Expectations in Q320

Orthopedic robotics is still in the early stages of adoption with SmartTRAK estimating that more than 25% of US hospitals have a robot and that fewer than 18% of TKA procedures in the US will have been performed robotically by YE2020. However, Stryker* noted in its Q320 earnings call that orthopedic robotic adoption (MAKO*) has started to reach an inflection point with an uptick in momentum that includes increasing interest, multiple installations in centers, placements into teaching hospitals and a shift to ASCs. Increasing competition from Zimmer Biomet’s* ROSA* and the launch of Smith & Nephew’s* CORI* second-generation robotic platform, has helped to push accounts that were thinking about purchasing a robot to follow through.

Among the many topics, including company revenues, shares, charts and expert analysis, covered in the comprehensive Q320 CAS Ortho Market Recap* are:

Topics: Orthopedics
Continue Reading
2 min read

Reaching A Tipping Point in Market Acceptance: Q320 CAS Spine Recap

By Julianne Burns on 12/23/20 9:30 AM

Continuing robotic implant pull-through and achievement of enabling technology milestones reflect increasing importance of CAS Spine technology in Q320.

Similar to market dynamics in recon robotics, spine robotics are beginning to reach a tipping point in market acceptance. In its Q320 earnings call, CEO Dave Demski noted that Globus Medical* is seeing increasing interest in its Excelsius GPS* robot and that the Company is in a different part of the robotic adoption curve, with surgeons well beyond their initial skepticism as robots have become more mainstream. Globus and Medtronic* have the strongest positions in enabling technology and robotics in spine. However, competition will be heating up over the next several years.

Continue Reading
2 min read

COVID Casting Shadows of Doubt on a Rebound: Q320 Spine Market Recap

By Julianne Burns on 12/11/20 11:40 AM

Rising COVID cases in the US casting shadows of doubt on ongoing rebound for the Spine market. 

Quarterly results hint at a sustained rebound for the Spine market even as the US faces a surge of COVID cases. WW Spine Hardware revenues were up as surgeons worked through a backlog of patients postponed due to COVID-19. The US Spinal Fusion Market saw a +3.6% uptick in Q320, with the US Disc Replacement market, VCF and Dynamic Devices all showing growth, according to SmartTRAK Financial Dashboard.

In an October Needham Spine & Robotics Expert Call, Spine surgeon Dr. Peter Whang noted that he and his peers were operating at full capacity at the time with a large backlog of patients to work through. In order to catch up on cases, accommodations are being made with extended clinic hours and elective cases scheduled on weekends. Dr. Whang affirms that COVID has accelerated the shift of spine procedures to an ASC setting and notes that ASC cases recovered faster and will be more resistant to any restrictions due to future COVID spikes.

Among the many topics covered in the comprehensive Q320 Spine Market Recap* are:

Continue Reading
2 min read

Dramatic Decline In Spine: Q220 Spine Market Recap

By Julianne Burns on 10/2/20 9:30 AM

The effects of COVID-19 were felt throughout the WW Spine Market with dramatic Q220 declines in both the US and international markets. 

COVID-19 stifled the Spine Hardware Market in Q220, driving WW revenues down -26.4% in the quarter, with the US at -30.5%. The US Spinal Fusion Market took the hardest hit, with that market seeing a -31.4% decline in Q220 vs US Disc Replacement and VCF Markets at -26.6% and -24.6%, respectively, according to SmartTRAK Financial Dashboard. Needham estimates that Medtronic* gained the most spine share in Q220, with DePuy Synthes* losing the most. 

Among the many topics covered in the comprehensive Q220 Spine Market Recap* are:

Continue Reading
4 min read

COVID-Era Consolidation in Spine

By Julianne Burns on 8/20/20 10:19 AM

Tracking the surge of Spine M&A activity during COVID-19.

The med device market downturn related to COVID-19 has led to a notable uptick in M&A activity across the board, with a number of acquisitions that will impact the Spine market.

Recent Deals
Perhaps the most notable deal has been Medtronic's* (MDT) agreement to acquire Medicrea, a manufacturer of custom spine implants, for about €7.00 per share, a premium of 22% over the closing price of shares on July 14. The acquisition is expected to close by the end of 2020.

Continue Reading

    Recent Articles